Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on April 24, 2025
Vertigenics Reviews (2025) Detailed Analysis of The Best Vertigo Supplement Backed by Science And Real Results!
GlobeNewswire
·
April 24, 2025
ORLANDO, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Vertigenics is a dietary formula that aims to strengthen the body’s natural balance system and reduce symptoms of vertigo. The nutritional supplement features an herbal blend of ingredients, each chosen for …
Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025
GlobeNewswire
·
April 24, 2025
GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou la « Société », www.koelis.com), société leader et innovante dans le domaine du traitement des maladies de la prostate, a annoncé ce jour un nouveau …
Best Dental Implants in Seattle Done by Dr. Javadi
GlobeNewswire
·
April 24, 2025
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Top Seattle periodontist and dental implant surgeon Dr. Ellie Javadi of Orchid Periodontics …
OBI Pharma annonce l’exposition d’affiches au congrès annuel de l’AACR 2025 concernant les conjugués anticorps-médicaments (CAM) OBI-992 et OBI-902, les technologies habilitantes relatives aux CAM GlycOBI® et ThiOBI®, le promédicament OBI-3424 et la sc…
GlobeNewswire
·
April 24, 2025
TAIPEI, Taïwan, 24 avr. 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx : 4174. TWO) a communiqué aujourd’hui des données non cliniques sur OBI-902, un CAM anti-TROP2 potentiellement le meilleur de sa catégorie, développé à l’aide de la nouvelle génération …
Koelis Announces Partnership with Bot Image™ at AUA 2025
GlobeNewswire
·
April 24, 2025
GRENOBLE, France and PRINCETON, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in prostate care, announced today a new partnership with Bot Image™ (Omaha, NE, USA) to serve the …
American Kidney Fund Announces 2025 Class of Corporate Members Providing Support in the Fight Against Kidney Disease
GlobeNewswire
·
April 24, 2025
ROCKVILLE, Md., April 24, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announces its 2025 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program. Corporate Members provide vital support to AKF’s …
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
GlobeNewswire
·
April 24, 2025
Company Changes Corporate Name to Align with its AI Products and Core Vision Knoxville, TN, April 24, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, today …
The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025
GlobeNewswire
·
April 24, 2025
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced the Fourth Annual Liam Johnson Memorial Golf Outing …
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
GlobeNewswire
·
April 24, 2025
SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, …
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
GlobeNewswire
·
April 24, 2025
VALENCIA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will host its inaugural Acute Wound Care Showcase …
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
GlobeNewswire
·
April 24, 2025
HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that its proprietary Gen-2 …
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 24, 2025
CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that …
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com
GlobeNewswire
·
April 24, 2025
ROSEVILLE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Via IBN -- InnerScope Hearing Technologies (OTC: INND) is proud to announce the official grand opening of OTCHealthMart.com, a cutting-edge online platform designed to make healthcare products …
Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 on Monday, April 28th at 8:30 AM ET
GlobeNewswire
·
April 24, 2025
SOUTH SAN FRANCISCO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
GlobeNewswire
·
April 24, 2025
THE WOODLANDS, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced its technology and early proof- …
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
GlobeNewswire
·
April 24, 2025
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development. VivoSim will offer liver and intestinal toxicology …
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
GlobeNewswire
·
April 24, 2025
ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2025 first quarter …
X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host Conference Call and Webcast on May 1, 2025
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will report financial results for the first quarter ended March …
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
GlobeNewswire
·
April 24, 2025
– Expands Development Portfolio with Introduction of a Novel Program Targeting PSC – – Confirms Highly Specific Allosteric ACLY Inhibitor Shown to Reduce Liver Injury, Inflammation and Fibrosis Across Multiple PSC-Relevant Pre-Clinical Models – – …
BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 24, 2025
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …